Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

ENSA and ARPP19 differentially control cell cycle progression and development.

Hached K, Goguet P, Charrasse S, Vigneron S, Sacristan MP, Lorca T, Castro A.

J Cell Biol. 2019 Jan 9. pii: jcb.201708105. doi: 10.1083/jcb.201708105. [Epub ahead of print]

PMID:
30626720
2.

Biochemical analyses reveal amino acid residues critical for cell cycle-dependent phosphorylation of human Cdc14A phosphatase by cyclin-dependent kinase 1.

Ovejero S, Ayala P, Malumbres M, Pimentel-Muiños FX, Bueno A, Sacristán MP.

Sci Rep. 2018 Aug 8;8(1):11871. doi: 10.1038/s41598-018-30253-8.

3.

The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1.

Boada-Romero E, Serramito-Gómez I, Sacristán MP, Boone DL, Xavier RJ, Pimentel-Muiños FX.

Nat Commun. 2016 Jun 8;7:11821. doi: 10.1038/ncomms11821.

4.

Orderly progression through S-phase requires dynamic ubiquitylation and deubiquitylation of PCNA.

Álvarez V, Viñas L, Gallego-Sánchez A, Andrés S, Sacristán MP, Bueno A.

Sci Rep. 2016 May 6;6:25513. doi: 10.1038/srep25513.

5.

Human Cdc14A regulates Wee1 stability by counteracting CDK-mediated phosphorylation.

Ovejero S, Ayala P, Bueno A, Sacristán MP.

Mol Biol Cell. 2012 Dec;23(23):4515-25. doi: 10.1091/mbc.E12-04-0260. Epub 2012 Oct 10.

6.

WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.

Mackintosh C, García-Domínguez DJ, Ordóñez JL, Ginel-Picardo A, Smith PG, Sacristán MP, de Álava E.

Oncogene. 2013 Mar 14;32(11):1441-51. doi: 10.1038/onc.2012.153. Epub 2012 May 28.

PMID:
22641220
7.

Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription.

Guillamot M, Manchado E, Chiesa M, Gómez-López G, Pisano DG, Sacristán MP, Malumbres M.

Sci Rep. 2011;1:189. doi: 10.1038/srep00189. Epub 2011 Dec 12.

8.

Cdc14 phosphatase promotes segregation of telomeres through repression of RNA polymerase II transcription.

Clemente-Blanco A, Sen N, Mayan-Santos M, Sacristán MP, Graham B, Jarmuz A, Giess A, Webb E, Game L, Eick D, Bueno A, Merkenschlager M, Aragón L.

Nat Cell Biol. 2011 Oct 23;13(12):1450-6. doi: 10.1038/ncb2365.

9.

Human Cdc14A becomes a cell cycle gene in controlling Cdk1 activity at the G₂/M transition.

Sacristán MP, Ovejero S, Bueno A.

Cell Cycle. 2011 Feb 1;10(3):387-91. Epub 2011 Feb 1.

10.

Human Cdc14A phosphatase modulates the G2/M transition through Cdc25A and Cdc25B.

Vázquez-Novelle MD, Mailand N, Ovejero S, Bueno A, Sacristán MP.

J Biol Chem. 2010 Dec 24;285(52):40544-53. doi: 10.1074/jbc.M110.133009. Epub 2010 Oct 18.

11.

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).

Olivares JM, Rodriguez-Morales A, Diels J, Povey M, Jacobs A, Zhao Z, Lam A, Villalobos Vega JC, Cuéllar JA, de Castro FJ, Quintero CM, Martíin JF, Domínguez P, Ojeda JL, Cortés SS, Cala FI, Marín CG, Castro LM, Duaso MA, Albarracín JR, Vergara GN, Benítez AF, Cleries FM, Pérez-Brian JM, Aragón AB, Navarro JC, Biedma JA, de Pedro RB, González JF, López ME, Moreno HD, López JA, Rodríguez EO, de Hoyos CM, Sacristán MP, Martín MD, Ballesteros EM, Rodríguez PA, Menéndez LF, Rivas RS, del Pino Cuadrado P, Lauffer JC, Solano JJ, Martínez JM, Solano FG, Rodríguez PG, Rodríguez JA, Cano TR, Fortacin MD, Lobeiras JM, Sampedro JM, Bravo AP, Pellicer AF, López MD, Liste JF, Fernández MR, Losada AC, Mendez RV, Romero SA, Blanco JJ, Bonaselt IT, Mahia MC, del Valle EF, Yañez PQ, Camarasa MG, Alonso JA, Mendez GF, Feliz FD, Lamela MA, Piñero MV, Alvarado PF, Gómez IL, Martín PF, Gómez JL, López AG, Jiménez AR, Nafs AE, Barquero NC, Ortiz RF, Noguera JL, Carrasco PR, Muñoz JM, Palma MM, Hortelano CM, Bonome LS, Sevilla JS, Juan JM, Ramos JM, Muñoz JL, Guisasola JE, Vazquez LS, Guerras FC, Nebot FJ, Fernández FJ, Nicolau AL, Subirats RC, Kidias MM, Navarro VF, García BF, del Rosal FM, de Vicente Muñoz T, Ballester JA, Lieb PM, Martel AD, Bea ER, Joaquim IG, Enjuanes FB, Piñol MB, Carbonell EF, Muñoz RM, Giribets CA, Sans LA, Blanco AS, Felipe MA, Muñoz PG, Villanueva AP, Arroyo MB, Borri RC, Fallada SM, Merola MC, Rodon EP, Palmes JR, Martínez EP, Catala JM, Coca AS, Ferrandiz FP, Paya EF, Caballero GI, Bonet AF, Figueras JF, Pagador PM, Garibo MM, Camo VP, Carrillo CS, Valero CP, Rebollo FJ, García Campayo J, Sala Ayma JM, Roig MM, de Uña Mateos MA, Bertolin RG, García AM, Mazo FJ, Velasco JL, Pérez LS, Casado CJ, Barba JJ, Diaz MC, Rubio JP, Mandoli AS, Herrero AU, Martínez AR, Serrano PS, Rodríguez EN, Montesinos JS, Macia JF, Mateos Marcos AM, Soto JV, Dumont MV, Pagan JP, Martínez VB, Santiuste de Pablos M, Delgado CE, Quiles MD, López FJ, Navarro PP, Torres AM, Ingles FJ, Arias-Camison JM, Manzano JC, Peña RV, Guitarte GP, Fontecilla HB, Romero JB, Gil RS, Lozano JM, Adanez LD, Zarranz Herrera-Oria I, Jiménez JP, Vaz FC, García OS, Anton CC, Casula RR, Hernandez MC, Escabias FT, Torresano JR, Pérez-Villamil AH, Estevez L, Figuero MA, Muñoz de Morales A, Calvin JL, Criado MD, Rodríguez VM, Ambrosolio EB, Madera PM, Alfaro GP, Vidal MM, Valtuille AG, Ruiz O, Cabornero GL, Echevarria Martínez de Bujo M, Mallen MJ, Puigros JS, Martorell AL, Forteza AC, Arrebola ER, Rodríguez de la Torre M, Saiz CG, Bardolet I Casas C, Linde ER, De Arce Cordon R, Molina EM, Carazo FJ, Romero JJ, Cano DV, Dorado MS, Velazquez SC, Sánchez AJ, Leon SO, Sánchez KP, Benitez MH, Zugarramurai AI, Contreras MA, De la Varga González M, Marín PB, Robina FG, García MS, Pérez FJ, Bros PC, Gómez AC, de Dios Molina Martín J, Perera JL, Averbach MC, Perera JL, Palancares EG, Gallego de Dios MT, Rojo CF, Iglesias SS, Merino MI, Mestre NP, Urdaniz AP, Sánchez JM, Seco RG, Muñoz JF, Agut MM, Lozano ML, Herguedas FM, Pena AT, García JV, Martínez AV, Sanz Granado OS, Fernández MA, Canseco JM, López PA, Martín MA, Barrio JA, Ubago JG, Bennassar MR, Díez JM, Fleta JL, Fortes FP, López CA, Medina O, Alvarez DF, Roca JM, Valladolid GR, Tavera JA, García-Castrillon Sales JA, Llordes IB, Melgarejo CA, Cañas de la Paz F, Callol VV, García MB, García JB, Leal FJ, Corrales EC, Iglesias ES, Gómez MA, Serrano GG, Chillarón EG, Aguado FJ, Castillo JJ, González AG, Vázquez JG, Peralvarez MB, Diaz MR, Mesa MY, Artiles FJ, Chao MA, Mesa MY, del Rosario Santana P, Escudero MA, Berenguer MM, Llacer JM, Berna JA, Ortiz JB, Pardell LT, Hernández-Alvarez de Sotomayor C, Méndez MR, Garate RC, Múgica BD, González MC, Domingo JP, Navarro CS, Vera GS, Cuquerella MA, Monzo JL, Boada PC, Pérez MF, Parrado EC, Sánchez JJ, Fernández JC; e-STAR Spanish Study Group.

Eur Psychiatry. 2009 Jun;24(5):287-96. doi: 10.1016/j.eurpsy.2008.12.002. Epub 2009 Feb 4.

PMID:
19195847
12.

Human Cdc14A reverses CDK1 phosphorylation of Cdc25A on serines 115 and 320.

Esteban V, Vázquez-Novelle MD, Calvo E, Bueno A, Sacristán MP.

Cell Cycle. 2006 Dec;5(24):2894-8. Epub 2006 Dec 15.

13.

Functional homology among human and fission yeast Cdc14 phosphatases.

Vázquez-Novelle MD, Esteban V, Bueno A, Sacristán MP.

J Biol Chem. 2005 Aug 12;280(32):29144-50. Epub 2005 May 23.

14.

Predominance of human versus rat phenotype in the metabolic pathways for bile acid synthesis by hybrid WIF-B9 cells.

Monte MJ, Badia MD, Serrano MA, Sacristan MP, Cassio D, Marin JJ.

Biochim Biophys Acta. 2001 Nov 30;1534(1):45-55.

PMID:
11750886
15.

Molecular cloning and characterization of the 5' region of the mouse trkA proto-oncogene.

Sacristán MP, de Diego JG, Bonilla M, Martín-Zanca D.

Oncogene. 1999 Oct 14;18(42):5836-42.

16.

Proximal promoter sequences mediate cell-specific and elevated expression of the favorable prognosis marker TrkA in human neuroblastoma cells.

Chang BB, Persengiev SP, de Diego JG, Sacristan MP, Martin-Zanca D, Kilpatrick DL.

J Biol Chem. 1998 Jan 2;273(1):39-44.

17.

T-cadherin 2: molecular characterization, function in cell adhesion, and coexpression with T-cadherin and N-cadherin.

Sacristán MP, Vestal DJ, Dours-Zimmermann MT, Ranscht B.

J Neurosci Res. 1993 Apr 15;34(6):664-80.

PMID:
8315665
18.

Antinociceptive activity of glycosidic enkephalin analogues.

Rodríguez RE, Rodríguez FD, Sacristán MP, Torres JL, Reig F, García Antón JM, Valencia G.

Psychopharmacology (Berl). 1990;101(2):222-5.

PMID:
2349363
19.

In vivo release of CCK-8 from the dorsal horn of the rat: inhibition by DAGOL.

Rodríguez RE, Sacristán MP.

FEBS Lett. 1989 Jul 3;250(2):215-7.

20.

New glycosylpeptides with high antinociceptive activity.

Rodriguez RE, Rodriguez FD, Sacristán MP, Torres JL, Valencia G, Garcia Antón JM.

Neurosci Lett. 1989 Jun 5;101(1):89-94.

PMID:
2549457

Supplemental Content

Loading ...
Support Center